Evidence map›Paper›PMID 40344371›Full record

Trial reportMolecular nutrition & food research2025

Mediterranean Diet Modulates Gene Expression of Cholesterol Efflux Receptors in High-Risk Cardiovascular Patients.

Javier Hernando-Redondo, Álvaro Hernáez, Albert Sanllorente, Xavier Pintó, Ramón Estruch, Jordi Salas-Salvadó, Dolores Corella, Fernando Arós, Miguel Ángel Martínez-González, Isaac Subirana and 11 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Molecular nutrition & food research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Javier Hernando-RedondoConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0002-6777-1649
Álvaro HernáezBlanquerna School of Health Sciences, University Ramon Llull, Barcelona, Spain.
Albert SanllorenteConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Xavier PintóConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Ramón EstruchConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Jordi Salas-SalvadóConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0003-2700-7459
Dolores CorellaConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Fernando ArósConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Miguel Ángel Martínez-GonzálezConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0002-3917-9808
Isaac SubiranaCIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Daniel Muñoz-AguayoConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Mireia MalcampoUnit of Cardiovascular Risk and Nutrition, Hospital del Mar Medical Research Institute, Barcelona, Spain.
Lluis Serra-MajemConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Dora RomagueraConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Jose LapetraConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Emilio RosConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Francisco TinahonesConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Rosa Maria Lamuela-RaventósConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0002-1287-4560
Enrique Gómez-GraciaConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Montserrat FitóConsorcio CIBER, Pathophysiology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
Olga CastañerUnit of Cardiovascular Risk and Nutrition, Hospital del Mar Medical Research Institute, Barcelona, Spain.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2021 SGR 00144Agència de Gestió d'Ajuts Universitaris i de Recerca CB06/03/0028Amb el suport de la Fundació La Marató de TV3: 202312-30-31-32-33Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición CB06/03/0028Contrato Rio Hortega CM20/00085Instituto de Salud Carlos III funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union PI21/00024;CP21/00097;PI18/00020;PI19/00017;PI16/00533;PI13/00233;PI20/00012;PI17/00214
6 · The paper itself

Abstract

In this study, we investigated gene expression related to cholesterol efflux receptors in individuals at high cardiovascular risk undergoing Mediterranean dietary interventions. Through transcriptomic analysis, we examined samples from two randomized controlled trials: PREDIMED and PREDIMED-Plus, with 151 and 89 elderly adults, respectively. Blood cells were isolated at baseline and after a 12-month intervention. In the PREDIMED trial, participants followed different Mediterranean diets: one supplemented with extra-virgin olive oil (traditional Mediterranean diet enriched with extra-virgin olive oil [MedDiet-EVOO]), another with nuts (MedDiet enriched with nuts MedDiet-Nuts [MedDiet-Nuts]), and a low-fat control diet. The PREDIMED-Plus trial compared an energy-reduced Mediterranean diet (Er-MedDiet) with physical activity to an ad libitum Mediterranean diet. Over time, mild but significant upregulation of genes like ATP binding cassette subfamily A member 1 (ABCA1), retinoid X receptor alpha (RXRA), retinoid X receptor beta (RXRB), and Nuclear Receptor Subfamily 1 Group H Member 3 (NR1H3) was observed in response to MedDiet-EVOO, MedDiet-Nuts, and Er-MedDiet. Notably, RXRA expression was higher in both MedDiet-EVOO and MedDiet-Nuts compared to the control diet. Differences in gene expression, particularly RXRA, ATP binding cassette subfamily G member 1 (ABCG1), NR1H3, and Peroxisome Proliferator Activated Receptor Delta (PPARD), were evident between MedDiet-Nuts and the control diet. In the PREDIMED-Plus trial, no significant differences in gene expression were found between dietary groups. Principal component analysis (PCA) and linear discriminant analysis (LDA) showed overlapping gene expression profiles across different Mediterranean diet interventions. In conclusion, our study highlights the cardiovascular health benefits of long-term adherence to a Mediterranean diet, both normocaloric and hypocaloric, primarily reflected by mild upregulation of cholesterol efflux-related genes-specifically involving RXRA, RXRB, ABCA1, ABCG1, Nuclear Receptor Subfamily 1 Group H Member 2(NR1H2), and PPARD-among elderly adults at high cardiovascular risk. This suggests a potential mechanism by which these diets may exert cardiovascular protective effects.

Indexed as

Cardiovascular DiseasesCholesterolDiet, MediterraneanAgedATP Binding Cassette Transporter 1FemaleGene Expression RegulationHumansMaleMiddle AgedNutsOlive OilABCA1 protein, humanATP Binding Cassette Transporter 1CholesterolOlive Oilcardiovascular riskMediterranean dietnutrigenomicomicsrandomized controlled trialtranscriptomic

Identifiers

PMID40344371
PMCPMC12236127

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.